.png){kind=logo}
GC Asia
IPOs under microscope as Chr Hansen and Life get ready
The EMEA IPO market will face a stern test next week when Danish biotech firm Chr Hansen and South African healthcare group Life price their IPOs, which together hope to raise around $1.8bn.
No deals were due to be priced this week so Europe was spared an IPO wipeout as markets swung wildly. The EuroStoxx 50 index went from 2,764.31 on May 12 to 2,488.50 on Tuesday — a fall of 10% — before recovering later during the week to close
...
Already a subscriber? Login
-
Latest news from Equity
-
Rhône Capital sells Fluidra stock after profits surge
20 Jan 2021 -
Lockdown woe brings 'Spoons back for another round of equity
20 Jan 2021 -
Jefferies banker joins Baird for consumer coverage
20 Jan 2021 -
Apollo Hospitals nets $160m from hot QIP
20 Jan 2021 -
China Modern Dairy pockets HK$1.56bn from share sale
20 Jan 2021
-
-
Latest news from Equity
-
Rhône Capital sells Fluidra stock after profits surge
20 Jan 2021 -
Lockdown woe brings 'Spoons back for another round of equity
20 Jan 2021 -
Jefferies banker joins Baird for consumer coverage
20 Jan 2021 -
Apollo Hospitals nets $160m from hot QIP
20 Jan 2021 -
China Modern Dairy pockets HK$1.56bn from share sale
20 Jan 2021
-
